The world's first anabolic‐androgenic steroid testing trial: A two‐phase pilot combining chemical analysis, results dissemination and community feedback
Thirteen percent of 23 anabolic-androgenic steroid (AAS) samples analysed contained substances different from what was expected. Interviews with active AAS users highlighted the need for reliable information, accessible testing services and tailored health approaches for AAS use.
Authors
- Steph Reeve
- Cameron Francis
- Ross Coomber (ORCID: https://orcid.org/0000-0002-8144-1996)
- Timothy M. Piatkowski (ORCID: https://orcid.org/0000-0002-6177-0266)
- Geoff Davey
- Beverly C. Walters (ORCID: https://orcid.org/0000-0002-5244-4282)
- Karen Blakey
- Monica Jane Barratt (ORCID: https://orcid.org/0000-0002-1015-9379)
- Sarah L. Cresswell (ORCID: https://orcid.org/0000-0002-1988-0701)
- Jason Ferris (ORCID: https://orcid.org/0000-0001-7474-0173)
- Michael E. Harding (ORCID: https://orcid.org/0000-0002-3633-493X)
- Cheneal Puljević (ORCID: https://orcid.org/0000-0002-3658-9772)
- Emma Kill
- Alan G. White
Institutions
- Griffith University (AU)
- Queensland Health (AU)
- University of Liverpool (GB)
- The University of Queensland (AU)
- IP Australia (AU)
- UNSW Sydney (AU)
- RMIT University (AU)
Publication Details
- Journal
- Addiction
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1111/add.70009
- Citations
- 28
- Primary Topic
- Hormonal and reproductive studies
- Type
- article
- Field-Weighted Citation Impact
- 36.26
Funders
- Mental Health Commission
- Griffith University